baber/WOPTO huggingface dataset:
Patent NZ-517389-A (NZ)
Title: Multi layer continuous paper printer
Inventor: MUSUMECI PHILLIP
IPC: B41J21/00
Filed: 2000-08-18
Abstract: A method of printing that enables simultaneous printing multiple  paper  streams  with a combination  of  fixed  and variable  information is disclosed. The method is useful  in combination   with   high-speed  form   collators   handling multiple  paper  streams.  The  method  uses  a  web   based graphics  editor program to develop page layout  information incorporating fixed and variable image information  using  a web   based   graphics  editor  program.  The  page   layout information is manipulated by an image processing  computer, said  image  processing computer including a digital  signal processing  system  adapted  to  analyse  the  page   layout information  into a pixel data corresponding  to  fixed  and variable  information to be printed and dividing  the  pixel data into a plurality of data packets. The data packets  are delivered  to  a  respective print head in  a  plurality  of print  head  arrays.  Each  of  the  print  head  arrays  is associated  with a separate paper stream to thereby  produce printing on multiple streams simultaneously.
Patent NZ-524505-A (NZ)
Title: A ventilator for a transport container
Inventor: CAREY NIGEL DEAN
IPC: F24F7/007
Filed: 2003-03-03
Abstract: A ventilator (1) for a transport container (2) having a body (3) and a fan (4).  The body (3) has a plenum chamber (12) and an inlet (13) to and an outlet (14) from the chamber (12).  In use, the ventilator (1) is placed within the container (2) such that the body (3) extends across the container (2), the inlet (13) is directed towards an open door (43) of the container (2) and the outlet (14) is directed towards a closed end (44) of the container (2) containing palletised goods (41, 46), such as onions.  The fan (4) draws air through the open door (43) and moves the air through the plenum chamber (12).  Air leaving the plenum chamber (12) circulates within the pallets (41) and alongside the palletised goods (46), and exits the container (2) via the open door (43).
Patent NZ-528277-A (NZ)
Title: Dynamically downloading and executing system services on a wireless device
Inventor: SPRIGG STEPHEN A
IPC: G06F9/445
Filed: 2002-03-18
Abstract: A method for supporting a download of an application from a server to a wireless device is disclosed. The method includes the steps of: (a) downloading the application and an associated reference from the server, (b) determining, prior to execution of the application, and based upon the associated reference, whether execution of the application requires a virtual machine to be loaded on the wireless device, (c) if the determining step determines that the virtual machine is required for execution of the application, performing the a second step of determining whether the virtual machine is loaded on the wireless device. If the second determining step determines that the virtual machine is not loaded on the wireless device, a second download request is sent to the server for the virtual machine and the virtual machine is downloaded, thereby making it available to the application. The steps of first determining, second determining, sending a second download request, and making the virtual machine available, are performed automatically on the wireless device without interaction with a user of the wireless device.
Patent NZ-528981-A (NZ)
Title: Cladding system related to sealing buidling structures
Inventor: HAYNES ANDREW LEO
IPC: E04D3/40
Filed: 2003-10-16
Abstract: A building cladding to be applied to a cladding substrate is disclosed, wherein the building cladding has a cladding of fusible material such as thermoplastic polyurethane which is at least in part attached by fusing to fastenings, wherein the fastenings at least penetrate the cladding substrate, wherein by further fusion to itself the cladding material forms a generally continuous cladding membrane over the cladding substrate, wherein the fusion is caused by fusible welding such as thermal or ultrasonic. A method of providing a weatherproof membrane on a building substrate is also disclosed.
Patent NZ-530390-A (NZ)
Title: 40 kDa protein expressed on fetal thymocytes but not adult thymocytes, antibodies and uses thereof
Inventor: ROCK KENNETH L
IPC: A61K39/395
Filed: 2000-07-18
Abstract: A substantially pure protein is characterized by: (i) a molecular weight of 40 kDa (ii) expression on the surface of fetal thymocytes (iii) no expression on the surface of adult thymocytes (iv) the ability to block cell proliferation upon binding by an antibody; and (v) the ability to induce homotypic aggregation upon binding by the antibody, wherein the antibody binds to fetal thymocytes, inhibits proliferation of, and induces apoptosis in a cell upon binding to the cell and does not bind adult thymocytes, and/or adult bone marrow adult B and/or T cells. Preferably the protein binds to a monoclonal antibody produced by hybridoma cell lines ATCC No. PTA-377, PTA-404, or PTA-405. (62) Divided out of 516771
Patent NZ-534090-A (NZ)
Title: Wind directional skylight vent
Inventor: WEST SHANE
IPC: E04D13/03
Filed: 2002-12-13
Abstract: A wind directional vent and skylight combination including: (a) a throat which may be in the form of a hood rotatably mounted to a structure such as a building and in communication with a cavity to be exhausted such as a room of the building; (b) wind directional means associated with the hood , the wind directional means optionally being inherent in the shape and configuration of the hood , the wind directional means causing the hood to rotate in response to changes in wind direction, wherein the hood is made from material adapted to permit the passage of light therethrough.
Patent NZ-536405-A (NZ)
Title: A multi-electrode lead
Inventor: ANDERSON NEIL LAWRENCE
IPC: A61B5/296
Filed: 2003-05-09
Abstract: A multi-electrode catheter lead includes an elongate carrier and a plurality of conductors 22A, 22B etc carried by the carrier. Several spaced apart electrodes A, B, C. are electrically connected to each one of the conductors and all of the electrodes are arranged at axially spaced intervals along the carrier. An electrode, A, connected to a conductor 22A is ever only adjacent to an electrode B connected to another conductor 22B once. That is, the electrodes on either side of any electrode are never connected to the same conductor. The electrodes may by sampled to determine the position of occurrence of an electrical property of the body vessel into which the catheter is inserted, and thereafter the catheter itself may be used as a guide body for an ablation electrode 56 mounted on a hollow tube 20 that can be slipped along the catheter to the position requiring ablation therapy.
Patent NZ-539750-A (NZ)
Title: Gas jet process and apparatus for high-speed amplification of DNA
Inventor: NELSON R MICHAEL
Filed: 2002-11-01
Abstract: Processes and apparatus for performing fast, precise, and reliable gas jet thermocycling on a sample using of pressurized gases delivered to a thermostated reaction chamber at high velocity using computer controlled electronic multiport valves are disclosed. Apparatus for achieving these processes are also disclosed.
Patent NZ-540669-A (NZ)
Title: Methods and kits for diagnosing and treating B-cell chronic lymphocytic leukemia (B-CLL)
Inventor: HERTZ ANNE METTE BUHL
IPC: C12Q1/68
Filed: 2003-11-19
Abstract: Disclosed are methods and kits for detecting several polynucleotide sequence found to be indicative of a poor prognosis of B-CLL. All the polynucleotides are transcribed from a region on human chromosome 12p21-22. Most of the polynucleotides do not encode larger polypeptides, but may encode small peptides, they may function as RNAs. Four polynucleotides encode a novel protein, which in one preferred embodiment can be used as a cytokine, preferably as an interleukin.
Patent NZ-540775-A (NZ)
Title: Nutritional composition comprising milk protein hydrolysate for use in the nutritional management and therapy of liver failure patients, inflammatory disease and hepatitis
Inventor: KUME HISAE
IPC: A23L33/15
Filed: 2003-11-21
Abstract: The onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-á and interleukin 6 (IL-6) production in macrophages. Fig.1 is a reverse-phase chromatogram of the UF permeate (molecular weight cutoff: 10,000) of a whey protein isolate (WPI) hydrolysate.
Patent NZ-541189-A (NZ)
Title: Process for conversion of cyanopyridines to nicotinamides and catalyst therefor, process for preparing said catalyst
Inventor: RAY SUBHASH CHANDRA
Filed: 2002-12-23
Abstract: Disclosed is a process for conversion of cyanopyridines to nicotinamides comprising dissolving the cyanopyridine in water; adding a transition metal catalyst prepared in neutral medium, refluxing the reaction mixture, cooling filtering and washing the resultant mixture and evaporating the filtrate to dryness to obtain the product.
Patent NZ-550868-A (NZ)
Title: Fruit treating apparatus and procedures
Inventor: EVANS LIONEL GORDON
Filed: 2004-06-10
Abstract: Apparatus for a method of enhancing food safety and longevity of produce that has been subject to a mechanical reduction, the apparatus having a first immersion apparatus to receive and to discharge produce pieces, a second immersion apparatus to receive the discharge from the first immersion apparatus and to discharge the produce pieces, and at least one of a vibratory conveyor and/or an air knife between the immersion apparatus, the conveyor and/or air knife to have the effect of shedding excess liquid on the produce pieces prior to the second immersion apparatus receiving the discharge from the first immersion apparatus.
Patent NZ-561006-A (NZ)
Title: Dihydroimidazothiazole derivatives
Inventor: BARBA OSCAR
IPC: A61K31/429
Filed: 2006-02-08
Abstract: Disclosed are dihydroimidazothiazole derivative compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. These compounds exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition, and are useful for the treatment of obesity.
Patent NZ-562163-A (NZ)
Title: Injection device with syringe cap and carrier to restrain rotation of the syringe relative to the housing during cap removal
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/20
Filed: 2006-04-03
Abstract: An injection device (110) comprises a housing (112) having a syringe (114) with a discharge nozzle (118). The syringe is movable between a retracted position in which the discharge nozzle is contained within the housing and an extended position in which the discharge nozzle extends from the housing. There is a syringe cap (not shown) for enclosing the discharge nozzle. The syringe cap is removable from the syringe by rotation relative to the syringe. A syringe carrier (150) in the housing is adapted to restrain rotation of the syringe relative to the housing as the cap is removed.
Patent NZ-565694-A (NZ)
Title: Waterproof vapour-permeable shoe
Inventor: POLEGATO MORETTI MARIO
IPC: A43B7/08
Filed: 2006-07-17
Abstract: A waterproof and water vapor-permeable shoe, which comprises: a bottom shoe part (11), which comprises a sole (12) that is perforated through from the tread toward the foot resting region, a top part (13), which surrounds the foot completely and in turn comprises, from the inside outwardly, a vapor-permeable or perforated lining (14), a membrane (15), which is waterproof and vapor-permeable and surrounds the foot completely, and a vapor-permeable or perforated upper (16).; The outer bottom portion (17) of the top shoe part (13) which is superimposed on the perforated area of the sole (12), is constituted by a portion (15a) of the membrane (15). A vapor-permeable or perforated protective element (22) for the portion (15a) of the membrane (15) is provided below the portion (15a) of the membrane (15) and above the tread of the sole (12). The material arranged below the portion (15a) of the membrane (15) and in direct contact therewith is waterproof and/or does not retain liquids.; A water sealing region (A) is provided between the portion (15a) of the membrane (15) and the sole (12), around the perforated area of the sole, and separates the flaps of the upper from the perforated area of the sole (12). Other embodiments are disclosed within the same general concept.
Patent NZ-566401-A (NZ)
Title: Topical antifungal compositions of terbinafine with hydroxypropylcellulose and an octylacrylamide acrylate copolymer
Inventor: MAYER FRIEDRICH KARL
IPC: A61K9/06
Filed: 2006-09-27
Abstract: Disclosed is a topical antifungal composition comprising between 0.75 % w/w and 20 % w/w of terbinafine or a pharmaceutically active salt form thereof, between 0.05 % w/w and 30% w/w of hydroxypropylcellulose, between 1% w/w and 10% w/w of an octylacrylamide acrylate copolymer, and a solvent selected from the group consisting of ethanol, isopropanol, acetone and ethyl acetate. Also disclosed is the use of a topical antifungal composition as defined above for the manufacture of a medicament for the treatment of a fungal skin infection, wherein the medicament is formulated to provide treatment with only one application.
Patent NZ-566488-A (NZ)
Title: Cyclbutayl compounds useful as Histamine-3 receptor antagonists
Inventor: WAGER TRAVIS T
IPC: A61K31/165
Filed: 2006-10-16
Abstract: Disclosed herein is a cyclobutyl compound of formula (I) wherein the substituents are defined within the specification, pharmaceutical compositions comprising said compounds, processes for their preparation, and to uses of such compounds in the manufacture of medicaments for the treatment of disorders or conditions that may be treated by antagonizing histamine-3 (H3) receptors, such as anxiety disorders, attention-deficit hyperactivity disorder, attention-deficit disorder, respiratory diseases, obesity, cognitive disorders and psychotic disorders.
Patent NZ-569844-A (NZ)
Title: Suppressing microbial growth in pulp and paper
Inventor: RICE LAURA R
IPC: C02F1/72
Filed: 2007-01-24
Abstract: Disclosed is a composition for antimicrobial effect in a water system, which composition comprises: a free chlorine-generating biocide comprising a chlorine source; urea; and an alkali in a concentration sufficient to provide a pH of from 12 to 13.5, the composition being further characterized in that it excludes stabilized bromine. Also disclosed is a method for stabilizing chlorine for use as a water treatment biocide in a process system.
Patent NZ-579563-A (NZ)
Title: Exercise device for step aerobics
Inventor: MNICH AXEL
IPC: A63B22/18
Filed: 2008-03-10
Abstract: A step exerciser (10) for step aerobics, with a substantially rigid platform (13) positioned on top of substantially circular sidewall. The sidewall comprises a first inflatable tubular member (14), which is situated atop a second inflatable tubular member (16), which is situated upon a support surface. The first inflatable member has a means for engaging the platform on its top surface and engaging the second inflatable member on its bottom surface. The sidewall structure provides a resilient, elevated support for the rigid platform, wherein the stability of the sidewall is adjustable by independently adjusting the air pressures in the first and second inflatable tubular members.
Patent NZ-583768-A (NZ)
Title: 4-stroke cycle internal combustion engine
Inventor: TABINOKI YUKIHISA
IPC: F01L1/46
Filed: 2010-03-08
Abstract: A vehicle-carried 4-stroke cycle internal combustion engine is disclosed. The vehicle-carried 4-stroke cycle internal combustion engine includes a valve chamber, a cam chain chamber, a valve chamber wherein valve motion is accommodated between a cylinder head and a head cover, a driving cam chain sprocket wheel and a driven cam chain sprocket, and a breather chamber. The cam chain chamber is formed from the cylinder head and the cylinder head cover for accommodating a valve motion transmission system cam chain. A cam chain is wrapped around the driving cam chain sprocket wheel and driven cam chain sprocket wheel. The breather chamber is formed between an upper portion of the head cover and the valve chamber where a barrier formed in an arcuate shape opposing to and extending along an outer circumference of the driven sprocket wheel from between the cam chain sprocket wheels is provided sidewardly of the driven sprocket wheel on the breather chamber side.
Patent NZ-585775-A (NZ)
Title: Novel pyrimidine derivatives
Inventor: BOLLI MARTIN
IPC: C07D413/04
Filed: 2008-10-31
Abstract: Disclosed is a pyrimidine compound of formula (I), wherein A is a 5 membered heterocyclic ring with at least two heteroatoms, and the other substituents are disclosed within the specification. Use of the said compound for the preparation of a pharmaceutical composition for the prevention or treatment of diseases or disorders associated with an activated immune system, is also disclosed.
Patent NZ-588346-A (NZ)
Title: Ratings system that provides a review form in response to the scanning of a visual identifier
Inventor: SAHUGUET ARNAUD
IPC: G06V30/224
Filed: 2009-03-30
Abstract: 588346 Disclosed is a computer-implemented review method. The method includes: storing information about a plurality of rateable entities; receiving a machine-readable representation (105) that encodes an identification code associated with a rateable entity of the plurality of rateable entities; and decoding the machine-readable representation (105) to obtain the identification code and retrieve the information. The method further includes: creating a ratings form (145), for providing a review (150) of the rateable entity, based on the identification code and the information; and providing the review (150) of the rateable entity to a central computer system (130) using the review form (145).
Patent NZ-595163-A (NZ)
Title: Control of key ethylene hormone signaling pathway proteins in plants
Inventor: ROSICHAN JEFFREY L
IPC: C12N15/00
Filed: 2010-03-02
Abstract: Disclosed is a gene expression system for controllable expression of ethylene response in a plant cell includes an activation cassette comprising a DNA-binding domain that recognizes a response element; an ecdysone receptor ligand binding domain; and an activation domain; and a target cassette comprising an inducible promoter, which comprises, in operative association, the response element and a minimal promoter responsive to the activation domain. The inducible promoter controls the expression of a nucleic acid sequence that encodes a selected regulatory protein that modifies sensitivity to ethylene of certain signal proteins in the plant. Interaction among the components of the activation cassette and target cassette, when in a plant cell, in the presence of an inducing composition, increases expression of the selected regulatory protein, and in turn decreases expression and accumulation of the signal protein in the plant, thereby and decreasing ethylene sensitivity in the plant cell. This increase in the expression of the regulatory protein, particularly in the presence of ethylene, is controlled by the timing, the concentration and the duration of the application of the inducing composition. Transgenic plant cells, tissues, organs and entire plants are provided, which in the presence of the inducing composition control ethylene sensitivity. Ethylene sensitivity and/or ethylene production in such transgenic plants and tissues may be controlled for purposes of manipulating ripening, flower senescence and other ethylene sensitive functions of the plant.
Patent NZ-596115-A (NZ)
Title: Panel mount system
Inventor: ALLEN WARWICK JAMES
IPC: E04C1/42
Filed: 2011-10-31
Abstract: 596115 A panel mount 1 for non-penetrative fastening of a panel (such as a glass pane), comprises mounting means for mounting the panel mount 1 to a side of a structure such that at least a portion of the panel, once fastened, extends above a top surface of the structure, a pair of clamp jaws 4, 5 defining an elongate slot in which an edge of a panel can be received, two intermediate clamping members 14, 15 one located adjacent each clamp jaw 4, 5 and to be positioned between each clamp jaw and the panel such that a panel can be clamped between the intermediate clamping members 14, 15 to secure it at the slot. Each intermediate clamping member 14, 15 has at least one threaded member 18, 19 associated with it. The threaded member(s) 18, 19 facilitate adjustment of the intermediate clamping member to which it is associated relative to its adjacent clamping jaw and independently of the other intermediate clamping member. At least one of the intermediate clamping members 14, 15 is adjustable by movement of at least one of the threaded members in a direction parallel to the elongate direction of the slot.
Patent NZ-596555-A (NZ)
Title: Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
Inventor: TSUKITA SACHIKO
IPC: A61K31/5575
Filed: 2010-05-26
Abstract: 596555 Disclosed herein is the use of a fatty acid derivative of the formula (III) for modulating a claudin-mediated function in a mammalian. Additionally disclosed is the use of the fatty acid derivative in the treatment or prevention of a dermatological condition, such as skin ulcer or bed sore, or a disease treatable or preventable by modulating an epidermal barrier function in a mammalian subject. In one embodiment the fatty acid derivative is (-)-7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptanoic acid or its salt, ether, ester or amide.
Patent NZ-597008-A (NZ)
Title: Meningococcal vaccine based on lipooligosaccharide (los) and neisseria meningitidis protein
Inventor: HAENSLER JEAN
IPC: A61K39/39
Filed: 2010-05-12
Abstract: Discloses a vaccine composition treating N. meningitidis infections. The composition comprises a lipo-oligosaccharide (LOS) of N. meningitidis formed especially from a lipid A, an inner core, an alpha chain of L8 type and the lipidised subunit B (Tpb B) of the human transferrin receptor of a strain of N. meningitidis or a lipidised fragment of this TpbB. The heptose II residue of the inner core bears an optional phosphoethanolamine (PEA) substituent in positions 0-6 and 0-7. Further disclosed are TpbB which may be from selected N. meningitidis strains. The vaccine LOS and TpbB components may formulated together in liposome forms.
Patent NZ-598092-A (NZ)
Title: Methods and compositions comprising specific strains of trichoderma atroviride for the biological control of soil borne plant pathogens and promoting plant growth
Inventor: STEWART ALISON
IPC: A01N63/38
Filed: 2009-02-13
Abstract: Discloses a composition and methods comprising a reproductively viable form and amount of: Trichoderma atroviride NMI No. V08/002389. Further discloses a composition that further comprises at least one additional strain of Trichoderma atroviride selected from Trichoderma atroviride NMI No. V08/002388 and Trichoderma atroviride NMI No. V08/002390. The composition finds application as a biological control agent to control selected soil borne pathogens and increase plant growth.